Related references
Note: Only part of the references are listed.Primary bladder mucosa-associated lymphoid tissue lymphoma A case report and literature review
Hewei Xu et al.
MEDICINE (2020)
Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement
Dai Chihara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology, and End Results Database
Xuejiao Yin et al.
FRONTIERS IN ONCOLOGY (2019)
Chronic Inflammation: Accelerator of Biological Aging
Bertrand Fougere et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2017)
Primary Urinary Tract Lymphoma: Rare but Aggressive
Konstantinos Lontos et al.
ANTICANCER RESEARCH (2017)
Clinicopathologic Characteristics and Treatment of Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)
Markus Raderer et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Primary bladder lymphoma, diffuse large B-cell type: Case report and literature review of 26 cases
W. Greg Simpson et al.
UROLOGY ANNALS (2015)
Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: An analysis of the Surveillance, Epidemiology and End Results database
Jorge J. Castillo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma
Adam J. Olszewski et al.
LEUKEMIA RESEARCH (2014)
Lymphoma of the Urinary Bladder
Anthony Kodzo-Grey Venyo
ADVANCES IN UROLOGY (2014)
Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy
Sari Riihijarvi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab
Lynette Ngo et al.
LEUKEMIA & LYMPHOMA (2008)
Pro-posed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
Lindsay M. Morton et al.
BLOOD (2007)
How I treat patients with diffuse large B-cell lymphorna
James O. Armitage
BLOOD (2007)
Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia
LH Sehn et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The age distribution of cancer and a multi-stage theory of carcinogenesis
P Armitage et al.
BRITISH JOURNAL OF CANCER (2004)
Immunosenescence, autoimmunity, and rheumatoid arthritis
CM Weyand et al.
EXPERIMENTAL GERONTOLOGY (2003)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
